SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genomic Valley Biotech informs about board meeting

16 May 2017 Evaluate

In pursuant of Reg. 29 of SEBI (LODR) Reg., 2015, Genomic Valley Biotech has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 29.05.2017, to consider and approve the Audited Financial Results for the quarter and year ended 31st March, 2017 at G-74 Pushkar Enclave, Paschim Vihar, Delhi - 110063. Further pursuant to Reg. 30 of SEBI (LODR) Reg., 2015 and SEBI (PIT) Reg., 2015 and Code of Conduct to Regulate, Monitor and Report, Trading by Insiders of the Company, the trading window for dealing in securities of the Company shall remain closed from 16.05.2017 till 31.05.2017.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

29.89 0.89 (3.07%)
16-Apr-2026 13:38 View Price Chart
Peers
Company Name CMP
Venkys India 1516.65
Mangalam Global Ent 12.63
Kaveri Seed 917.85
Regaal Resources 80.22
Simran Farms 162.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×